Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 2, 2007, Pages

  Fang, Wen Feng ^a,b   Cho, Jae Hwa ^a,c   He, Qianbin ^a   Lin, Meng Chih ^b,d   Wu, Chao Chien ^b   Voelkel, Norbert F ^a   Douglas, Ivor S ^a,e,f  

^a UNIVERSITY OF COLORADO   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c Inha University   (South Korea)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e DENVER HEALTH MEDICAL CENTER   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

Extracellular signal regulated kinase p44 42; Kdo2 lipid A; Lipopolysaccharide

Indexed keywords

LIPID A; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 4;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; CYTOKINES; ENZYME INHIBITORS; FLAVONOIDS; LIPID A; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEROXIDASE; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 34547614977     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00011.2007     Document Type: Article

References (48)

1. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, Millar AB. Expression of functional Toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 31: 241-245, 2004.
2. Arndt PG, Young SK, Lieber JG, Fessler MB, Nick JA, Worthen GS. Inhibition of c-Jun N-terminal kinase limits lipopolysaccharide-induced pulmonary neutrophil influx. Am J Respir Crit Care Med 171: 978-986, 2005.
3. Bigatello LM, Greene RE, Sprung CL, Panacek EA, Straube RC, Zimmerman JL, Maunder RJ, Lanken PN, Pile-Spellmann E, Stanek KS, Zaslavsky A, Zapol WM. HA-1A in septic patients with ARDS: results from the pivotal trial. Intensive Care Med 20: 328-334, 1994.
4. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 133: 913-927, 1986.
5. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164: 966-972, 2000.
6. Cluff CW, Baldridge JR, Stover AG, Evans JT, Johnson DA, Lacy MJ, Clawson VG, Yorgensen VM, Johnson CL, Livesay MT, Hershberg RM, Persing DH. Synthetic Toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. Infect Immun 73: 3044-3052, 2005.
7. Ding A, Hwang S, Lander HM, Xie QW. Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B. J Leukoc Biol 57: 174-179, 1995.
8. Faure K, Sawa T, Ajayi T, Fujimoto J, Moriyama K, Shime N, Wiener-Kronish JP. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir Res 5: 1, 2004.
9. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171-194, 2003.
10. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001.
11. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N. Lipopolysaccharide activation of the MEKERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98: 1429-1439, 2001.
12. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si-Tahar M. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 279: 2712-2718, 2004.
13. Guo RF, Riedemann NC, Sun L, Gao H, Shi KX, Reuben JS, Sarma VJ, Zetoune FS, Ward PA. Divergent signaling pathways in phagocytic cells during sepsis. J Immunol 177: 1306-1313, 2006.
14. Heumann D. CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria. J Endotoxin Res 7: 439-441, 2001.
15. Issekutz AC, Megyeri P, Issekutz TB. Role for macrophage products in endotoxin-induced polymorphonuclear leukocyte accumulation during inflammation. Lab Invest 56: 49-59, 1987.
16. Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS. Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect Immun 73: 1754-1763, 2005.
17. Jeyaseelan S, Chu HW, Young SK, Worthen GS. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun 72: 7247-7256, 2004.
18. Khan SA, Everest P, Servos S, Foxwell N, Zahringer U, Brade H, Rietschel ET, Dougan G, Charles IG, Maskell DJ. A lethal role for lipid A in Salmonella infections. Mol Microbiol 29: 571-579, 1998.
19. Kim HJ, Lee HS, Chong YH, Kang JL. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225: 36-47, 2006.
20. Kim JH, Suk MH, Yoon DW, Lee SH, Hur GY, Jung KH, Jeong HC, Lee SY, Lee SY, Suh IB, Shin C, Shim JJ, In KH, Yoo SH, Kang KH. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291: L580-L587, 2006.
21. Kim JI, Lee CJ, Jin MS, Lee CH, Paik SG, Lee H, Lee JO. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem 280: 11347-11351, 2005.
22. Kitamura Y, Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K, Fujiwara I, Nakajima H. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 163: 762-769, 2001.
23. Kitchens RL, Munford RS. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 270: 9904-9910, 1995.
24. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598-625, 2005.
25. Kwak SH, Wang XQ, He Q, Fang WF, Mitra S, Bdeir K, Ploplis VA, Xu Z, Idell S, Cines D, Abraham E. Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway. Thromb Haemost 95: 829-835, 2006.
26. 2-terminal kinase or extracellular signal-regulated kinase improves lung injury. Respir Res 5: 23, 2004.
27. Lien E, Chow JC, Hawkins LD, McGuinness PD, Miyake K, Espevik T, Gusovsky F, Golenbock DT. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/Toll-like receptor 4 signaling pathway. J Biol Chem 276: 1873-1880, 2001.
28. Lomas-Neira J, Chung CS, Perl M, Gregory S, Biffl W, Ayala A. Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol 290: L51-L58, 2006.
29. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 121: 1-5, 1994.
30. Morrison DC, Leive L. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem 250: 2911-2919, 1975.
31. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, Suratt BT, Janes MS, Henson PM, Worthen GS. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 164: 2151-2159, 2000.
32. Oghiso Y, Yamada Y, Shibata Y. Exudation of proliferative macrophages in local inflammation in the peritoneum. J Leukoc Biol 52: 421-424, 1992.
33. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
34. Proctor RA, Will JA, Burhop KE, Raetz CR. Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun 52: 905-907, 1986.
35. 2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J Lipid Res 47: 1097-1111, 2006.
36. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700, 2002.
37. Rietschel ET, Kim YB, Watson DW, Galanos C, Luderitz O, Westphal O. Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun 8: 173-177, 1973.
38. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005.
39. Ryan LK, Karol MH. Acute respiratory response of guinea pigs to lipopolysaccharide, lipid A, and monophosphoryl lipid A from Salmonella minnesota. Am Rev Respir Dis 140: 1429-1435, 1989.
40. Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 109: 1026-1033, 2007.
41. Savov JD, Brass DM, Lawson BL, McElvania-Tekippe E, Walker JK, Schwartz DA. Toll-like receptor 4 antagonist (E5564) prevents the chronic airway response to inhaled lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 289: L329-L337, 2005.
42. Schultz J, Kaminker K. Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Arch Biochem Biophys 96: 465-467, 1962.
43. Soejima K, Ishizaka A, Urano T, Sayama K, Sakamaki F, Nakamura H, Terashima T, Waki Y, Tasaka S, Fujishima S, Kawata T, Christ WJ, Kanazawa M. Protective effect of B464, a lipid A analog, on endotoxin-induced cellular responses and acute lung injury. Am J Respir Crit Care Med 154: 900-906, 1996.
44. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167: 2250-2256, 2001.
45. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 12: 113-117, 2000.
46. Tosaki A, Maulik N, Elliott GT, Blasig IE, Engelman RM, Das DK. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J Pharmacol Exp Ther 285: 1274-1279, 1998.
47. Wang XQ, Bdeir K, Yarovoi S, Cines DB, Fang W, Abraham E. Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury. J Immunol 177: 5550-5557, 2006.
48. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.